IMC-Chicago »

Trevi Therapeutics shares owned by IMC-Chicago

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by IMC-Chicago from 13F filings

Historical chart of IMC-Chicago investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by IMC-Chicago consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by IMC-Chicago

Quarter filed Position value Share count Share price at filing
2025-09-30 $280k 31k 9.15

More positions owned by IMC-Chicago

Spdr S&p 500 Etf Tr Tr Unit Put Option
Spdr S&p 500 Etf Tr Tr Unit Call Option
Nvidia Corp option Put Option
Nvidia Corp option Call Option
Tesla Motors Inc cmn Call Option
Tesla Motors Inc cmn Put Option
Invesco Qqq Tr Unit Ser 1 Put Option
Invesco Qqq Tr Unit Ser 1 Call Option
Apple Inc option Call Option
Meta Platforms Cl A Call Option
Microstrategy Cl A New Call Option
Microsoft Corp Call Option
Netflix Inc put Put Option
Apple Inc option Put Option
Meta Platforms Cl A Put Option

View all positions for IMC-Chicago

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Viking Global Investors
Vivo Capital
Marshall Wace
Alliancebernstein
MPM Oncology Impact Management
OrbiMed Advisors
FMR
Wellington Management Company
Octagon Capital Advisors
Affinity Asset Advisors

View all funds holding Trevi Therapeutics